Abstract
Bipolar disorder is a severe and disabling mental disorder, characterized by unusual shifts in mood, energy, activity levels, concentration, and the ability to carry out day-to-day tasks; it is recurrent with a chronic course with persistent residual symptoms, cognitive impairment, problems in psychosocial functioning, and poor quality of life in a proportion of individuals. Many patients with bipolar disorder experience substantial symptomatology months or even years before full bipolar manifestation. Adequate diagnosis and treatment is often delayed, which is associated with a worse outcome. Psychosocial interventions may facilitate the high-risk youths’ acquisition of skills for coping with stress, developing social supports, and achieving autonomy.
In the last decade, the treatment target in clinical and research settings has focused not only on clinical remission, but also on functional recovery and, more lately, in personal recovery, taking into account patients’ well-being and quality of life. Hence, the trend in psychiatry and psychology is to treat bipolar disorder in an integrative and holistic manner. This chapter offers an overview regarding psychosocial functioning in bipolar disorder. First, a brief summary is provided regarding the definition of psychosocial functioning, the tools to measure it, and the related variables. Thereafter, we include a section discussing therapies with proven efficacy and other under study able to enhance functional outcomes or preventing functional decline. Finally, different interventions directed to improve patients’ well-being, quality of life, and personal recovery are briefly described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241–51.
Bonnín CM, Sánchez-Moreno J, Martínez-Arán A, Solé B, Reinares M, Rosa AR, et al. Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability. J Affect Disord. 2012;136(3):650–9. https://pubmed.ncbi.nlm.nih.gov/22051075/.
Martínez-Arán A, Vieta E, Reinares M, Colom F, Torrent C, Sánchez-Moreno J, et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry. 2004;161(2):262–70. http://www.ncbi.nlm.nih.gov/pubmed/14754775.
Michalak EE, Yatham LN, Lam RW. Quality of life in bipolar disorder: a review of the literature. Health Qual Life Outcomes. 2005;3:72. http://www.ncbi.nlm.nih.gov/pubmed/16288650.
MacQueen GM, Trevor Young L, Joffe RT. A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatr Scand. 2001;103:163–70.
Post RM, Altshuler L, Leverich GS, Frye MA, Suppes T, McElroy SL, et al. Relationship of clinical course of illness variables to medical comorbidities in 900 adult outpatients with bipolar disorder. Compr Psychiatry. 2015;56:21–8. http://www.ncbi.nlm.nih.gov/pubmed/25284280.
Sentissi O, Navarro JC, De Oliveira H, Gourion D, Bourdel MC, Baylé FJ, et al. Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients. Psychiatry Res. 2008;161(1):36–42. http://www.ncbi.nlm.nih.gov/pubmed/18786727.
Bennett F, Hodgetts S, Close A, Frye M, Grunze H, Keck P, et al. Predictors of psychosocial outcome of bipolar disorder: data from the Stanley Foundation Bipolar Network. Int J bipolar Disord. 2019;7(1):28. http://www.ncbi.nlm.nih.gov/pubmed/31840207.
Leverich GS, Post RM, Keck PE, Altshuler LL, Frye MA, Kupka RW, et al. The poor prognosis of childhood-onset bipolar disorder. J Pediatr. 2007;150(5):485–90. http://www.ncbi.nlm.nih.gov/pubmed/17452221.
Martinez-Aran A, Vieta E, Torrent C, Sanchez-Moreno J, Goikolea JM, Salamero M, et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 2007;9(1–2):103–13.
Levy B, Manove E. Functional outcome in bipolar disorder: the big picture. Depress Res Treat. 2012;2012:949248. http://www.ncbi.nlm.nih.gov/pubmed/21961062.
Vieta E, Torrent C. Functional remediation: the pathway from remission to recovery in bipolar disorder. World Psychiatry. 2016;15(3):288–9. http://www.ncbi.nlm.nih.gov/pubmed/27717267.
Dion G, Tohen M, Anthony W, Waternaux C. Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Community Psychiatry. 1988;39(6). https://pubmed.ncbi.nlm.nih.gov/3402925/.
Tohen M, Hennen J, Zarate CM, Baldessarini RJ, Strakowski SM, Stoll AL, et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry. 2000;157(2):220–8. http://www.ncbi.nlm.nih.gov/pubmed/10671390.
Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009;11(5):453–73. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=19624385&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5. http://www.ncbi.nlm.nih.gov/pubmed/17555558.
Zarate CA, Tohen M, Land M, Cavanagh S. Functional impairment and cognition in bipolar disorder. Psychiatry Q. 2000;71(4):309–29. http://www.ncbi.nlm.nih.gov/pubmed/11025910.
Von Korff M, Andrews G, Delves M. Assessing activity limitations and disability among adults. In: The conceptual evolution of DSM-5. Arlington, VA: American Psychiatric Publishing, Inc.; 2011. p. 163–88.
Ustün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010;88(11):815–23. http://www.ncbi.nlm.nih.gov/pubmed/21076562.
Vieta E, Cieza A, Stucki G, Chatterji S, Nieto M, Sánchez-Moreno J, et al. Developing core sets for persons with bipolar disorder based on the International Classification of Functioning. Disability and Health Bipolar Disord. 2007;9(1–2):16–24. http://www.ncbi.nlm.nih.gov/pubmed/17391346.
Ayuso-Mateos JL, Avila CC, Anaya C, Cieza A, Vieta E, Bipolar Disorders Core Sets Expert Group. Development of the International Classification of Functioning, Disability and Health core sets for bipolar disorders: results of an international consensus process. Disabil Rehabil. 2013;35(25):2138–46. http://www.ncbi.nlm.nih.gov/pubmed/23586666.
Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull. 2001;27(2):235–45. http://www.ncbi.nlm.nih.gov/pubmed/11354591.
Arbuckle R, Frye MA, Brecher M, Paulsson B, Rajagopalan K, Palmer S, et al. The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder. Psychiatry Res. 2009;165(1–2):163–74. http://www.ncbi.nlm.nih.gov/pubmed/19042030.
Leon AC, Solomon DA, Mueller TI, Turvey CL, Endicott J, Keller MB. The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychol Med. 1999;29(4):869–78. http://www.ncbi.nlm.nih.gov/pubmed/10473314.
Tohen M, Waternaux CM, Tsuang MT, Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry. 1990;47(12):1106–11. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=2244795&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Sanchez-Moreno J, Bonnin CM, González-Pinto A, Amann BL, Solé B, Balanzá-Martinez V, et al. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables. Acta Psychiatr Scand. 2018;138(2):145–54. http://www.ncbi.nlm.nih.gov/pubmed/29726004.
Kupfer DJ, Frank E, Grochocinski VJ, Cluss PA, Houck PR, Stapf DA. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry. 2002;63(2):120–5. http://www.ncbi.nlm.nih.gov/pubmed/11874212.
Wingo AP, Baldessarini RJ, Holtzheimer PE, Harvey PD. Factors associated with functional recovery in bipolar disorder patients. Bipolar Disord. 2010;12(3):319–26. http://www.ncbi.nlm.nih.gov/pubmed/20565439.
Keck PE, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry. 1998;155(5):646–52. http://www.ncbi.nlm.nih.gov/pubmed/9585716.
Samalin L, de Chazeron I, Vieta E, Bellivier F, Llorca P-M. Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder. Bipolar Disord. 2016;18(2):164–73. http://www.ncbi.nlm.nih.gov/pubmed/26946486.
Gitlin MJ, Mintz J, Sokolski K, Hammen C, Altshuler LL. Subsyndromal depressive symptoms after symptomatic recovery from mania are associated with delayed functional recovery. J Clin Psychiatry. 2011;72(5):692–7. https://pubmed.ncbi.nlm.nih.gov/20673560/.
Gutiérrez-Rojas L, Jurado D, Gurpegui M. Factors associated with work, social life and family life disability in bipolar disorder patients. Psychiatry Res. 2011;186(2–3):254–60. http://www.ncbi.nlm.nih.gov/pubmed/20647154.
Reinares M, Papachristou E, Harvey P, Mar Bonnín C, Sánchez-Moreno J, Torrent C, et al. Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J Affect Disord. 2013;144(1–2):65–71. http://www.ncbi.nlm.nih.gov/pubmed/22862890.
Murru A, Pacchiarotti I, Verdolini N, Reinares M, Torrent C, Geoffroy P-A, et al. Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2018;268(8):749–55. http://www.ncbi.nlm.nih.gov/pubmed/28534186.
Bonnín CM, Martínez-Arán A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, et al. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord. 2010;121(1–2):156–60. http://www.ncbi.nlm.nih.gov/pubmed/19505727.
Huxley N, Baldessarini RJ. Disability and its treatment in bipolar disorder patients. Bipolar Disord. 2007;9(1–2):183–96. http://www.ncbi.nlm.nih.gov/pubmed/17391360.
Sanchez-Moreno J, Martinez-Aran A, Gadelrab HF, Cabello M, Torrent C, Bonnin CM, et al. The role and impact of contextual factors on functioning in patients with bipolar disorder. Disabil Rehabil. 2010;32(Suppl 1):S94–104. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=20883145&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Etain B, Godin O, Boudebesse C, Aubin V, Azorin JM, Bellivier F, et al. Sleep quality and emotional reactivity cluster in bipolar disorders and impact on functioning. Eur Psychiatry. 2017;45:190–7. http://www.ncbi.nlm.nih.gov/pubmed/28957786.
Sanchez-Moreno J, Martinez-Aran A, Tabarés-Seisdedos R, Torrent C, Vieta E, Ayuso-Mateos JL. Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom. 2009;78(5):285–97. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=19602917&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Sanchez-Moreno J, Martinez-Aran A, Colom F, Scott J, Tabares-Seisdedos R, Sugranyes G, et al. Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use. J Clin Psychiatry. 2009;70(8):1120–7. http://www.ncbi.nlm.nih.gov/pubmed/19758523.
Leen J, Soczynska JK, Gallaugher LA, Woldeyohannes HO, Alsuwaidan MT, Cha DS, et al. The effect of personality dimensions on functional outcomes in mood disorders. Adv Ther. 2013;30(7):671–83. http://www.ncbi.nlm.nih.gov/pubmed/23839119.
Icick R, Gard S, Barde M, Carminati M, Desage A, Guillaume S, et al. Physical and mental health burden in cases of bipolar disorder classified as current, former, or non-tobacco smokers. J Affect Disord. 2017;208:406–13. http://www.ncbi.nlm.nih.gov/pubmed/27810725.
Kizilkurt OK, Gulec MY, Giynas FE, Gulec H. Effects of personality functioning on the global functioning of patients with bipolar disorder I. Psychiatry Res. 2018;266:309–16. http://www.ncbi.nlm.nih.gov/pubmed/29598836.
Williams TF, Simms LJ. Personality traits and maladaptivity: unipolarity versus bipolarity. J Pers. 2018;86(5):888–901. http://www.ncbi.nlm.nih.gov/pubmed/29171877.
Tsapekos D, Strawbridge R, Mantingh T, Cella M, Wykes T, Young AH. Role of cognitive reserve in cognitive variability in euthymic individuals with bipolar disorder: cross-sectional cluster analysis. BJPsych open. 2020;6(6):e133. http://www.ncbi.nlm.nih.gov/pubmed/33121561.
Jiménez-López E, Sánchez-Morla EM, Aparicio AI, López-Villarreal A, Martínez-Vizcaíno V, Rodriguez-Jimenez R, et al. Psychosocial functioning in patients with psychotic and non-psychotic bipolar I disorder. A comparative study with individuals with schizophrenia. J Affect Disord. 2018;229:177–85. http://www.ncbi.nlm.nih.gov/pubmed/29316520.
Bonnín CM, González-Pinto A, Solé B, Reinares M, González-Ortega I, Alberich S, et al. Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder. J Affect Disord. 2014;160:50–4. http://www.ncbi.nlm.nih.gov/pubmed/24709022.
Torres IJ, DeFreitas CM, DeFreitas VG, Bond DJ, Kunz M, Honer WG, et al. Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder. Psychol Med. 2011;41(5):971–82. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=20810001&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Jaeger J, Berns S, Loftus S, Gonzalez C, Czobor P. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord. 2007;9(1–2):93–102. http://www.ncbi.nlm.nih.gov/pubmed/17391353.
Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Influence of clinical and neuropsychological variables on the psychosocial and occupational outcome of remitted bipolar patients. Psychopathology. 2009;42(3):148–56. http://www.ncbi.nlm.nih.gov/pubmed/19276630.
Torres IJ, Kozicky J, Popuri S, Bond DJ, Honer WG, Lam RW, et al. 12-month longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder. Bipolar Disord. 2014;16(2):159–71. http://www.ncbi.nlm.nih.gov/pubmed/24636366.
Kozicky J-M, Torres IJ, Silveira LE, Bond DJ, Lam RW, Yatham LN. Cognitive change in the year after a first manic episode. J Clin Psychiatry. 2014;75(06):e587–93. http://article.psychiatrist.com/?ContentType=START&ID=10008687.
Demmo C, Lagerberg TV, Kvitland LR, Aminoff SR, Hellvin T, Simonsen C, et al. Neurocognitive functioning, clinical course and functional outcome in first-treatment bipolar I disorder patients with and without clinical relapse: a 1-year follow-up study. Bipolar Disord. 2018;20(3):228–37. http://www.ncbi.nlm.nih.gov/pubmed/29121444.
Watson S, Gallagher P, Porter RJ, Smith MS, Herron LJ, Bulmer S, et al. A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression. Biol Psychiatry. 2012;72(11):943–9. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=22770649&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Yatham LN, Mackala S, Basivireddy J, Ahn S, Walji N, Hu C, et al. Lurasidone versus treatment as usual for cognitive impairment in euthymic patients with bipolar I disorder: a randomised, open-label, pilot study. Lancet Psychiatry. 2017;4(3):208–17. http://www.ncbi.nlm.nih.gov/pubmed/28185899.
Miskowiak KW, Ehrenreich H, Christensen EM, Kessing LV, Vinberg M. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J Clin Psychiatry. 2014;75(12):1347–55. http://www.ncbi.nlm.nih.gov/pubmed/25099079.
Miskowiak KW, Vinberg M, Macoveanu J, Ehrenreich H, Køster N, Inkster B, et al. Effects of erythropoietin on hippocampal volume and memory in mood disorders. Biol Psychiatry. 2015;78(4):270–7. https://www.sciencedirect.com/science/article/abs/pii/S0006322314009974.
Miskowiak KW, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, et al. Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force. Bipolar Disord. 2017;19(8):614–26. http://www.ncbi.nlm.nih.gov/pubmed/28895274.
Bonnín CM, Martínez-Arán A, Reinares M, Valentí M, Solé B, Jiménez E, et al. Thresholds for severity, remission and recovery using the functioning assessment short test (FAST) in bipolar disorder. J Affect Disord. 2018;240:57–62. https://doi.org/10.1016/j.jad.2018.07.045.
Nierenberg AA, Loft H, Olsen CK. Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: a randomized, double-blinded, exploratory study with vortioxetine. J Affect Disord. 2019;250:35–42. http://www.ncbi.nlm.nih.gov/pubmed/30826492.
Deckersbach T, Nierenberg AA, Kessler R, Lund HG, Ametrano RM, Sachs G, et al. RESEARCH: cognitive rehabilitation for bipolar disorder: an open trial for employed patients with residual depressive symptoms. CNS Neurosci Ther. 2010;16(5):298–307. http://www.ncbi.nlm.nih.gov/pubmed/19895584.
Torrent C, Bonnin CM, Martínez-Arán A, Valle J, Amann BL, González-Pinto A, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry. 2013;170(8):852–9. http://www.ncbi.nlm.nih.gov/pubmed/23511717.
Bonnin CM, Torrent C, Arango C, Amann BL, Solé B, González-Pinto A, et al. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome. Br J Psychiatry. 2016;208(1):87–93. http://www.ncbi.nlm.nih.gov/pubmed/26541692.
Zyto S, Jabben N, Schulte PFJ, Regeer BJ, Kupka RW. A pilot study of a combined group and individual functional remediation program for patients with bipolar I disorder. J Affect Disord. 2016;194:9–15. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=26800305&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Demant KM, Vinberg M, Kessing LV, Miskowiak KW. Effects of short-term cognitive remediation on cognitive dysfunction in partially or fully remitted individuals with bipolar disorder: results of a randomised controlled trial. PLoS One. 2015;10(6):e0127955. http://www.ncbi.nlm.nih.gov/pubmed/26070195.
Lewandowski KE, Sperry SH, Cohen BM, Norris LA, Fitzmaurice GM, Ongur D, et al. Treatment to Enhance Cognition in Bipolar Disorder (TREC-BD): efficacy of a randomized controlled trial of cognitive remediation versus active control. J Clin Psychiatry. 2017;78(9):e1242–9. http://www.ncbi.nlm.nih.gov/pubmed/29045770.
Ott CV, Vinberg M, Kessing LV, Bowie CR, Forman JL, Miskowiak KW. Effect of action-based cognitive remediation on cognitive impairment in patients with remitted bipolar disorder: a randomized controlled trial. Bipolar Disord. 2020; http://www.ncbi.nlm.nih.gov/pubmed/33053258.
Lengvenyte A, Coppola F, Jaussent I, Courtet P, Olié E. Improved functioning following computerized working memory training (COGMED®) in euthymic patients with bipolar disorder and cognitive complaints: an exploratory study. J Affect Disord. 2020;262:414–21. http://www.ncbi.nlm.nih.gov/pubmed/31740107.
Sayegh L, Touré EH, Farquhar E, Beaulieu S, Renaud S, Rej S, et al. Group Cognitive Behavioral Analysis System of Psychotherapy (CBASP): a pilot study for bipolar depression. Front Psych. 2020;11:565681. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=33173513&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Gomes BC, Rocca CC, Belizario GO, Fernandes F, Valois I, Olmo GC, et al. Cognitive behavioral rehabilitation for bipolar disorder patients: a randomized controlled trial. Bipolar Disord. 2019;21(7):621–33. http://www.ncbi.nlm.nih.gov/pubmed/31025470.
Strawbridge R, Tsapekos D, Hodsoll J, Mantingh T, Yalin N, McCrone P, et al. Cognitive remediation therapy for patients with bipolar disorder: a randomised proof-of-concept trial. Bipolar Disord. 2020; http://www.ncbi.nlm.nih.gov/pubmed/32583630.
Tremain H, Fletcher K, Scott J, McEnery C, Berk M, Murray G. The influence of stage of illness on functional outcomes after psychological treatment in bipolar disorder: a systematic review. Bipolar Disord. 2020;22(7):666–92. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=32621794&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Leopold K, Bauer M, Bechdolf A, Correll CU, Holtmann M, Juckel G, et al. Efficacy of cognitive-behavioral group therapy in patients at risk for serious mental illness presenting with subthreshold bipolar symptoms: results from a prespecified interim analysis of a multicenter, randomized, controlled study. Bipolar Disord. 2020;22(5):517–29. http://www.ncbi.nlm.nih.gov/pubmed/32112496.
Stamm TJ, Zwick JC, O’Malley G, Sondergeld L-M, Hautzinger M. Adjuvant psychotherapy in early-stage bipolar disorder: study protocol for a randomized controlled trial. Trials. 2020;21(1):845. http://www.ncbi.nlm.nih.gov/pubmed/33050952.
Pfennig A, Leopold K, Martini J, Boehme A, Lambert M, Stamm T, et al. Improving early recognition and intervention in people at increased risk for the development of bipolar disorder: study protocol of a prospective-longitudinal, naturalistic cohort study (Early-BipoLife). Int J bipolar Disord. 2020;8(1):22. http://www.ncbi.nlm.nih.gov/pubmed/32607662.
Grunze H, Born C. The impact of subsyndromal bipolar symptoms on patient’s functionality and quality of life. Front Psych. 2020;11:510. http://www.ncbi.nlm.nih.gov/pubmed/32595531.
Samalin L, Boyer L, Murru A, Pacchiarotti I, Reinares M, Bonnin CM, et al. Residual depressive symptoms, sleep disturbance and perceived cognitive impairment as determinants of functioning in patients with bipolar disorder. J Affect Disord. 2017;210:280–6. http://www.ncbi.nlm.nih.gov/pubmed/28068616.
Martinez-Aran A, Vieta E. Cognition as a target in schizophrenia, bipolar disorder and depression. Eur Neuropsychopharmacol. 2015;25(2):151–7. http://www.ncbi.nlm.nih.gov/pubmed/25661911.
Gitlin MJ, Miklowitz DJ. The difficult lives of individuals with bipolar disorder: a review of functional outcomes and their implications for treatment. J Affect Disord. 2017;209:147–54. http://www.ncbi.nlm.nih.gov/pubmed/27914248.
Vieta E, Garriga M. Adjunctive antidepressants in bipolar depression. The lancet. Psychiatry. 2016;3(12):1095–6. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=28100424&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Radua J, Grunze H, Amann BL. Meta-analysis of the risk of subsequent mood episodes in bipolar disorder. Psychother Psychosom. 2017;86(2):90–8. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=28183076&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Garriga M, Solé E, González-Pinto A, Selva-Vera G, Arranz B, Amann BL, et al. Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: results from a pilot, randomized controlled trial. Eur Neuropsychopharmacol. 2017;27(10):959–69. http://www.ncbi.nlm.nih.gov/pubmed/28882405.
Novo P, Landin-Romero R, Radua J, Vicens V, Fernandez I, Garcia F, et al. Eye movement desensitization and reprocessing therapy in subsyndromal bipolar patients with a history of traumatic events: a randomized, controlled pilot-study. Psychiatry Res. 2014;219(1):122–8. http://www.ncbi.nlm.nih.gov/pubmed/24880581.
Moreno-Alcázar A, Treen D, Valiente-Gómez A, Sio-Eroles A, Pérez V, Amann BL, et al. Efficacy of eye movement desensitization and reprocessing in children and adolescent with post-traumatic stress disorder: a meta-analysis of randomized controlled trials. Front Psychol. 2017;8:1750. http://www.ncbi.nlm.nih.gov/pubmed/29066991.
Sanchez-Moreno J, Bonnín C, González-Pinto A, Amann BL, Solé B, Balanzá-Martínez V, et al. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study. Eur Neuropsychopharmacol. 2017;27(4):350–9. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=28126401&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
González Isasi A, Echeburúa E, Limiñana JM, González-Pinto A. Psychoeducation and cognitive-behavioral therapy for patients with refractory bipolar disorder: a 5-year controlled clinical trial. Eur Psychiatry. 2014;29(3):134–41. http://www.ncbi.nlm.nih.gov/pubmed/23276524.
Lam DH, Watkins ER, Hayward P, Bright J, Wright K, Kerr N, et al. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry. 2003;60(2):145–52. http://www.ncbi.nlm.nih.gov/pubmed/12578431.
Inder ML, Crowe MT, Luty SE, Carter JD, Moor S, Frampton CM, et al. Randomized, controlled trial of Interpersonal and Social Rhythm Therapy for young people with bipolar disorder. Bipolar Disord. 2015;17(2):128–38. http://www.ncbi.nlm.nih.gov/pubmed/25346391.
Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Kogan JN, Sachs GS, et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry. 2007;164(9):1340–7. http://www.ncbi.nlm.nih.gov/pubmed/17728418.
Steardo L, Luciano M, Sampogna G, Zinno F, Saviano P, Staltari F, et al. Correction to: efficacy of the interpersonal and social rhythm therapy (IPSRT) in patients with bipolar disorder: results from a real-world, controlled trial. Ann General Psychiatry. 2020;19(1):28. https://annals-general-psychiatry.biomedcentral.com/articles/10.1186/s12991-020-00278-3.
Crowe M, Inder M, Porter R, Wells H, Jordan J, Lacey C, et al. Patients’ perceptions of functional improvement in psychotherapy for mood disorders. Am J Psychother. 2020;74:22–9. http://www.ncbi.nlm.nih.gov/pubmed/33302704.
Williams JMG, Alatiq Y, Crane C, Barnhofer T, Fennell MJV, Duggan DS, et al. Mindfulness-based Cognitive Therapy (MBCT) in bipolar disorder: preliminary evaluation of immediate effects on between-episode functioning. J Affect Disord. 2008;107(1–3):275–9. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=17884176&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Ives-Deliperi VL, Howells F, Stein DJ, Meintjes EM, Horn N. The effects of mindfulness-based cognitive therapy in patients with bipolar disorder: a controlled functional MRI investigation. J Affect Disord. 2013;150(3):1152–7. http://www.ncbi.nlm.nih.gov/pubmed/23790741.
Perich T, Manicavasagar V, Mitchell PB, Ball JR. The association between meditation practice and treatment outcome in Mindfulness-based Cognitive Therapy for bipolar disorder. Behav Res Ther. 2013;51(7):338–43. http://www.ncbi.nlm.nih.gov/pubmed/23639299.
Stern Y. Cognitive reserve☆. Neuropsychologia. 2009;47(10):2015–28. http://www.ncbi.nlm.nih.gov/pubmed/19467352.
Forcada I, Mur M, Mora E, Vieta E, Bartrés-Faz D, Portella MJ. The influence of cognitive reserve on psychosocial and neuropsychological functioning in bipolar disorder. Eur Neuropsychopharmacol. 2015;25(2):214–22. https://pubmed.ncbi.nlm.nih.gov/25172270/.
Anaya C, Martinez Aran A, Ayuso-Mateos JL, Wykes T, Vieta E, Scott J. A systematic review of cognitive remediation for schizo-affective and affective disorders. J Affect Disord. 2012;142(1–3):13–21. http://www.ncbi.nlm.nih.gov/pubmed/22840620.
Ponsoni A, Damiani Branco L, Cotrena C, Milman Shansis F, Fonseca RP. The effects of cognitive reserve and depressive symptoms on cognitive performance in major depression and bipolar disorder. J Affect Disord. 2020;274:813–8. https://pubmed.ncbi.nlm.nih.gov/32664019/.
Amoretti S, Bernardo M, Bonnin CM, Bioque M, Cabrera B, Mezquida G, et al. The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study. Eur Neuropsychopharmacol. 2016;26(10):1638–48. http://linkinghub.elsevier.com/retrieve/pii/S0924977X16301018.
Vieta E. [Personalised medicine applied to mental health: precision psychiatry]. Rev Psiquiatr Salud Ment 2015;8(3):117–118. http://www.ncbi.nlm.nih.gov/pubmed/25959401.
de la Serna E, Montejo L, Solé B, Castro-Fornieles J, Camprodon-Boadas P, Sugranyes G, et al. Effectiveness of enhancing cognitive reserve in children, adolescents and young adults at genetic risk for psychosis: study protocol for a randomized controlled trial Rev Psiquiatr Salud Ment. 2021. https://linkinghub.elsevier.com/retrieve/pii/S188898912100029X.
Bhering Martins L, Braga Tibães JR, Sanches M, Jacka F, Berk M, Teixeira AL. Nutrition-based interventions for mood disorders. Expert Rev Neurother. 2021; http://www.ncbi.nlm.nih.gov/pubmed/33487078.
Balanzá-Martínez V, Shansis FM, Tatay-Manteiga A, López-García P. Diet and neurocognition in mood disorders—an overview of the overlooked. Curr Pharm Des. 2020;26(20):2353–62. http://www.ncbi.nlm.nih.gov/pubmed/32188376.
Mora E, Portella MJ, Martinez-Alonso M, Teres M, Forcada I, Vieta E, et al. The impact of obesity on cognitive functioning in euthymic bipolar patients: a cross-sectional and longitudinal study. J Clin Psychiatry. 2017;78(8):e924–32. http://www.ncbi.nlm.nih.gov/pubmed/28994517.
Bond DJ, Torres IJ, Lee SS, Kozicky J-M, Silveira LE, Dhanoa T, et al. Lower cognitive functioning as a predictor of weight gain in bipolar disorder: a 12-month study. Acta Psychiatr Scand. 2017;135(3):239–49. http://www.ncbi.nlm.nih.gov/pubmed/27995622.
Calkin C, van de Velde C, Růzicková M, Slaney C, Garnham J, Hajek T, et al. Can body mass index help predict outcome in patients with bipolar disorder? Bipolar Disord. 2009;11(6):650–6. http://www.ncbi.nlm.nih.gov/pubmed/19689507.
Bond DJ, Kunz M, Torres IJ, Lam RW, Yatham LN. The association of weight gain with mood symptoms and functional outcomes following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). Bipolar Disord. 2010;12(6):616–26. https://doi.org/10.1111/j.1399-5618.2010.00855.x.
Sylvia LG, Salcedo S, Bernstein EE, Baek JH, Nierenberg AA, Deckersbach T. Nutrition, exercise, and wellness treatment in bipolar disorder: proof of concept for a consolidated intervention. Int J bipolar Disord. 2013;1(1):24. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=24660139&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Gillhoff K, Gaab J, Emini L, Maroni C, Tholuck J, Greil W. Effects of a multimodal lifestyle intervention on body mass index in patients with bipolar disorder: a randomized controlled trial. Prim Care Companion J Clin Psychiatry. 2010;12(5). http://www.ncbi.nlm.nih.gov/pubmed/21274359.
Ernst C, Olson AK, Pinel JPJ, Lam RW, Christie BR. Antidepressant effects of exercise: evidence for an adult-neurogenesis hypothesis? J Psychiatry Neurosci. 2006;31(2):84–92. http://www.ncbi.nlm.nih.gov/pubmed/16575423.
Nuechterlein KH, Ventura J, McEwen SC, Gretchen-Doorly D, Vinogradov S, Subotnik KL. Enhancing cognitive training through aerobic exercise after a first schizophrenia episode: theoretical conception and pilot study. Schizophr Bull. 2016;42(Suppl 1):S44–52. http://www.ncbi.nlm.nih.gov/pubmed/27460618.
Campos C, Rocha NBF, Lattari E, Nardi AE, Machado S. Exercise induced neuroplasticity to enhance therapeutic outcomes of cognitive remediation in schizophrenia: analyzing the role of brain derived neurotrophic factor. CNS Neurol Disord Drug Targets. 2017;16(6):638–51. http://www.ncbi.nlm.nih.gov/pubmed/28017130.
Kern RS, Glynn SM, Horan WP, Marder SR. Psychosocial treatments to promote functional recovery in schizophrenia. Schizophr Bull. 2009;35(2):347–61. http://www.ncbi.nlm.nih.gov/pubmed/19176470.
Frank E, Wallace ML, Hall M, Hasler B, Levenson JC, Janney CA, et al. An integrated risk reduction intervention can reduce body mass index in individuals being treated for bipolar I disorder: results from a randomized trial. Bipolar Disord. 2015;17(4):424–37. http://www.ncbi.nlm.nih.gov/pubmed/25495748.
Colom F, Vieta E, Martínez-Arán A, Reinares M, Goikolea JM, Benabarre A, et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry. 2003;60(4):402. https://doi.org/10.1001/archpsyc.60.4.402.
Reinares M, Colom F, Sánchez-Moreno J, Torrent C, Martínez-Arán A, Comes M, et al. Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial. Bipolar Disord. 2008;10(4):511–9. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=18452447&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Torrent C, Del Mar Bonnin C, Martínez-Arán A, Valle J, Amann BL, González-Pinto A, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry. 2013;170(8):852–9.
Reinares M, Martínez-Arán A, Vieta E. Psychotherapy for bipolar disorders: an integrative approach. Cambridge: Cambridge University Press; 2020. p. 126. http://services.cambridge.org/us/academic/subjects/medicine/mental-health-psychiatry-and-clinical-psychology/psychotherapy-bipolar-disorders-integrative-approach?format=PB&isbn=9781108460095.
Morton E, Michalak EE, Murray G. What does quality of life refer to in bipolar disorders research? A systematic review of the construct’s definition, usage and measurement. J Affect Disord. 2017;212:128–37. http://www.ncbi.nlm.nih.gov/pubmed/28160685.
Bonnín CM, Yatham LN, Michalak EE, Martínez-Arán A, Dhanoa T, Torres I, et al. Psychometric properties of the well-being index (WHO-5) spanish version in a sample of euthymic patients with bipolar disorder. J Affect Disord. 2018;228:153–9. http://www.ncbi.nlm.nih.gov/pubmed/29248821.
Keyes CLM, Dhingra SS, Simoes EJ. Change in level of positive mental health as a predictor of future risk of mental illness. Am J Public Health. 2010;100(12):2366–71. http://www.ncbi.nlm.nih.gov/pubmed/20966364.
Nunes CS, Maes M, Roomruangwong C, Moraes JB, Bonifacio KL, Vargas HO, et al. Lowered quality of life in mood disorders is associated with increased neuro-oxidative stress and basal thyroid-stimulating hormone levels and use of anticonvulsant mood stabilizers. J Eval Clin Pract. 2018;24(4):869–78. http://www.ncbi.nlm.nih.gov/pubmed/29665163.
Rajagopalan K, Bacci ED, Ng-Mak D, Wyrwich K, Pikalov A, Loebel A. Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials. BMC Psychiatry. 2016;16:157.
Gonda X, Kalman J, Dome P, Rihmer Z. [Changes in quality of life and work function during phase prophylactic lamotrigine treatment in bipolar patients: 6 month, prospective, observational study]. Neuropsychopharmacol Hung. 2016;18(1):57–67.
Walker DJ, DelBello MP, Landry J, D’Souza DN, Detke HC. Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination. Child Adolesc Psychiatry Ment Health. 2017;11:34. http://www.ncbi.nlm.nih.gov/pubmed/28706563.
Vancampfort D, Van Damme T, Probst M, Firth J, Stubbs B, Basangwa D, et al. Physical activity is associated with the physical, psychological, social and environmental quality of life in people with mental health problems in a low resource setting. Psychiatry Res. 2017;258:250–4. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=28844560&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
O’Donnell LA, Axelson DA, Kowatch RA, Schneck CD, Sugar CA, Miklowitz DJ. Enhancing quality of life among adolescents with bipolar disorder: a randomized trial of two psychosocial interventions. J Affect Disord. 2017;219:201–8. http://www.ncbi.nlm.nih.gov/pubmed/28570966.
Lauder S, Chester A, Castle D, Dodd S, Gliddon E, Berk L, et al. A randomized head to head trial of MoodSwings.net.au: an Internet based self-help program for bipolar disorder. J Affect Disord. 2015;171:13–21. http://www.ncbi.nlm.nih.gov/pubmed/25282145.
Hidalgo-Mazzei D, Reinares M, Mateu A, Nikolova VL, Bonnín CDM, Samalin L, et al. OpenSIMPLe: a real-world implementation feasibility study of a smartphone-based psychoeducation programme for bipolar disorder. J Affect Disord. 2018;241:436–45. http://www.ncbi.nlm.nih.gov/pubmed/30145515.
Bauer R, Glenn T, Strejilevich S, Conell J, Alda M, Ardau R, et al. Internet use by older adults with bipolar disorder: international survey results. Int J bipolar Disord. 2018;6(1):20. http://www.ncbi.nlm.nih.gov/pubmed/30178112.
Hidalgo-Mazzei D, Reinares M, Mateu A, Juruena MF, Young AH, Pérez-Sola V, et al. Is a SIMPLe smartphone application capable of improving biological rhythms in bipolar disorder? J Affect Disord. 2017;223:10–6. http://www.ncbi.nlm.nih.gov/pubmed/28711743.
Bonnín CDM, Solé B, Reinares M, García-Estela A, Samalin L, Martínez-Arán A, et al. Does cognitive impairment in bipolar disorder impact on a SIMPLe app use? J Affect Disord. 2021;282:488–94. http://www.ncbi.nlm.nih.gov/pubmed/33422826.
IsHak WW, Brown K, Aye SS, Kahloon M, Mobaraki S, Hanna R. Health-related quality of life in bipolar disorder. Bipolar Disord. 2012;14(1):6–18. http://www.ncbi.nlm.nih.gov/pubmed/22329468.
Sylvia LG, Montana RE, Deckersbach T, Thase ME, Tohen M, Reilly-Harrington N, et al. Poor quality of life and functioning in bipolar disorder. Int J bipolar Disord. 2017;5(1):10. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=28188565&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Marwaha S, Durrani A, Singh S. Employment outcomes in people with bipolar disorder: a systematic review. Acta Psychiatr Scand. 2013;128(3):179–93. http://www.ncbi.nlm.nih.gov/pubmed/23379960.
Träger C, Decker L, Wæhrens EE, Knorr U, Miskowiak K, Vinberg M. Influences of patient informed cognitive complaints on activities of daily living in patients with bipolar disorder. An exploratory cross-sectional study. Psychiatry Res. 2017;249:268–74. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=28135597&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Ehrminger M, Brunet-Gouet E, Cannavo A-S, Aouizerate B, Cussac I, Azorin J-M, et al. Longitudinal relationships between cognition and functioning over 2 years in euthymic patients with bipolar disorder: a cross-lagged panel model approach with the FACE-BD cohort. Br J Psychiatry. 2021;218(2):80–7. http://www.ncbi.nlm.nih.gov/pubmed/31407639.
Salagre E, Dodd S, Aedo A, Rosa A, Amoretti S, Pinzon J, et al. Toward precision psychiatry in bipolar disorder: staging 2.0. Front Psych. 2018;9:641. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&DbFrom=pubmed&Cmd=Link&LinkName=pubmed_pubmed&LinkReadableName=RelatedArticles&IdsFromResult=30555363&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
del Mar Bonnin, C., Montejo, L., Martinez-Aran, A., Solé, B., Comes, M., Torrent, C. (2022). Psychosocial Recovery-Oriented Treatments in Bipolar Disorders. In: Carpiniello, B., Vita, A., Mencacci, C. (eds) Recovery and Major Mental Disorders. Comprehensive Approach to Psychiatry, vol 2. Springer, Cham. https://doi.org/10.1007/978-3-030-98301-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-98301-7_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-98300-0
Online ISBN: 978-3-030-98301-7
eBook Packages: MedicineMedicine (R0)